Loading...
Header Logo
Keywords
Last Name
Institution

Magdalena Bieniasz

TitleMember, Assistant
InstitutionOklahoma Medical Research Foundation
DepartmentFunctional and Chemical Genomics
Address825 NE 13th St
Oklahoma City OK
Phone405/271-2155
vCardDownload vCard

    Collapse Biography 
    Collapse education and training
    Medical University of Lodz, PolandPhD2008Medical Biochemistry

    Collapse Research 
    Collapse research activities and funding
    K22CA207602     (BIENIASZ, MAGDALENA)May 10, 2017 - Apr 30, 2020
    NIH
    The role of short-form Ron (sfRon) kinase in the pathogenesis of high-grade serous ovarian cancer
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Moxley KM, Wang L, Welm AL, Bieniasz M. Short-form Ron is a novel determinant of ovarian cancer initiation and progression. Genes Cancer. 2016 May; 7(5-6):169-81. PMID: 27551332; PMCID: PMC4979590.
    2. Bieniasz M, Radhakrishnan P, Faham N, De La O JP, Welm AL. Preclinical Efficacy of Ron Kinase Inhibitors Alone and in Combination with PI3K Inhibitors for Treatment of sfRon-Expressing Breast Cancer Patient-Derived Xenografts. Clin Cancer Res. 2015 Dec 15; 21(24):5588-600. PMID: 26289070.
      View in: PubMed
    3. Liu X, Zhao L, Derose YS, Lin YC, Bieniasz M, Eyob H, Buys SS, Neumayer L, Welm AL. Short-Form Ron Promotes Spontaneous Breast Cancer Metastasis through Interaction with Phosphoinositide 3-Kinase. Genes Cancer. 2011 Jul; 2(7):753-62. PMID: 22207901; PMCID: PMC3218405.
    4. Gil M, Bieniasz M, Wierzbicki A, Bambach BJ, Rokita H, Kozbor D. Targeting a mimotope vaccine to activating Fcgamma receptors empowers dendritic cells to prime specific CD8+ T cell responses in tumor-bearing mice. J Immunol. 2009 Nov 15; 183(10):6808-18. PMID: 19846865; PMCID: PMC2805007.
    5. Bieniasz M, Oszajca K, Eusebio M, Kordiak J, Bartkowiak J, Szemraj J. The positive correlation between gene expression of the two angiogenic factors: VEGF and BMP-2 in lung cancer patients. Lung Cancer. 2009 Dec; 66(3):319-26. PMID: 19324447.
      View in: PubMed
    6. Jamroziak K, Szemraj Z, Grzybowska-Izydorczyk O, Szemraj J, Bieniasz M, Cebula B, Giannopoulos K, Balcerczak E, Jesionek-Kupnicka D, Kowal M, Kostyra A, Calbecka M, Wawrzyniak E, Mirowski M, Kordek R, Robak T. CD38 gene polymorphisms contribute to genetic susceptibility to B-cell chronic lymphocytic leukemia: evidence from two case-control studies in Polish Caucasians. Cancer Epidemiol Biomarkers Prev. 2009 Mar; 18(3):945-53. PMID: 19240243.
      View in: PubMed
    7. Oszajca K, Bieniasz M, Brown G, Swiatkowska M, Bartkowiak J, Szemraj J. Effect of oxidative stress on the expression of t-PA, u-PA, u-PAR, and PAI-1 in endothelial cells. Biochem Cell Biol. 2008 Dec; 86(6):477-86. PMID: 19088796.
      View in: PubMed
    8. Kowalski M, Brown G, Bieniasz M, Oszajca K, Chabielska E, Pietras T, Szemraj Z, Makandjou-Ola E, Bartkowiak J, Szemraj J. Cloning and expression of a new recombinant thrombolytic and anthithrombotic agent - a staphylokinase variant. Acta Biochim Pol. 2009; 56(1):41-53. PMID: 19018330.
      View in: PubMed
    9. Bieniasz M, Bartkowiak J, Szemraj J. [Expression of bone morphogenetic proteins, matrix metalloproteinases and inhibitors of matrix metalloproteinases in lung cancers and their prognostic significance]. Postepy Biochem. 2008; 54(1):82-90. PMID: 18610585.
      View in: PubMed
    Bieniasz's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Physical Neighbors Expand Description
    _